08048035996
HERTI 440MG Injection wholesale and global supplier from India to Australia | Phoenix Exim.

1. General Information

Herti 440mg Injection is an intravenous trastuzumab formulation. Trastuzumab is a targeted monoclonal antibody that acts against the HER2 (human epidermal growth factor receptor 2) protein. HER2 is overexpressed in some breast and gastric cancers, making it an important therapeutic target.

The medicine is supplied as a powder for preparation of an intravenous infusion and requires appropriate cold-chain storage, generally 2–8°C, without freezing.

2. Product Information

  • Brand: Herti 440mg Injection
  • Active ingredient: Trastuzumab
  • Strength: 440mg/vial
  • Therapeutic class: Anticancer / monoclonal antibody
  • Dosage form: Powder for concentrate for solution for intravenous infusion
  • Route: Intravenous infusion
  • Manufacturer/Marketer: Hetero Healthcare Ltd.
  • Storage: Refrigerate at 2–8°C; do not freeze.
  • Prescription status: Prescription medicine

The 440mg trastuzumab vial is intended to be prepared and administered by trained healthcare professionals according to the applicable prescribing information.

3. Uses of Herti 440mg Injection

Herti 440mg may be used for appropriately selected patients with HER2-positive cancer, including:

  • HER2-positive breast cancer
  • HER2-positive metastatic breast cancer
  • HER2-positive gastric cancer
  • HER2-positive gastroesophageal junction cancer

Treatment may be given alone or together with other anti-cancer medicines depending on the cancer type, stage and treatment plan. HER2 status is determined through appropriate diagnostic testing before targeted treatment is selected.

4. Benefits of Herti 440mg Injection

The principal benefit of trastuzumab is its targeted action against HER2-positive cancer cells. By binding to HER2, it can interfere with signals involved in cancer-cell growth and survival and can also help immune cells recognize HER2-expressing cancer cells.

Potential clinical benefits include:

  • Targeted treatment for HER2-positive cancers
  • Helps inhibit HER2-mediated cancer-cell growth
  • May help control disease progression
  • Can be incorporated into combination cancer-treatment regimens when clinically appropriate

The expected benefit varies according to the cancer type, stage, HER2 status and other individual patient factors.

5. Side Effects of Herti 440mg Injection

Like other trastuzumab medicines, Herti can cause side effects. Some reactions occur during or shortly after infusion, while others may develop during treatment.

Potential side effects include:

  • Infusion-related reactions
  • Fever and chills
  • Fatigue
  • Headache
  • Nausea or vomiting
  • Diarrhea
  • Cough
  • Rash
  • Muscle or joint pain
  • Weakness

More serious risks include cardiac dysfunction/cardiomyopathy, serious infusion or allergic reactions, and pulmonary toxicity.

6. Common Side Effects

Reported side effects may include:

  • Fever
  • Chills
  • Headache
  • Nausea
  • Diarrhea
  • Fatigue
  • Cough
  • Rash
  • Dizziness
  • Back or joint pain
  • Vomiting
  • Swelling/edema
  • Infusion-site or infusion-related reactions

If symptoms are persistent, severe or unusual, the treating healthcare professional should be contacted promptly.

7. How to Use Herti 440mg Injection

Herti 440mg is not a self-administered medicine. It is prepared and administered as an intravenous infusion by qualified healthcare professionals in an appropriate clinical setting.

The dosage and treatment interval depend on the indication and the patient's clinical condition. Trastuzumab regimens may involve a loading dose followed by maintenance doses; therefore, the exact dose must be determined by the oncologist rather than copied from general product information.

Patients are monitored during treatment, particularly for infusion reactions and other clinically significant adverse effects.

8. How Herti 440mg Injection Works

Herti contains trastuzumab, which specifically binds to the HER2 receptor on the surface of HER2-expressing cancer cells.

This targeted binding can:

  1. Block HER2-related growth signaling.
  2. Reduce signals that promote cancer-cell proliferation and survival.
  3. Help the immune system identify and attack HER2-expressing cancer cells.

As a result, trastuzumab can help slow the growth and progression of HER2-positive cancer.

9. Safety Advice

  • Prescription use: Use only under the supervision of an oncologist or qualified healthcare professional.
  • Heart: Cardiac function should be assessed before and during treatment because trastuzumab can cause cardiomyopathy and reduced cardiac function.
  • Infusion reactions: Patients should be monitored for reactions during and following infusion.
  • Lungs: Report breathing difficulties or other new pulmonary symptoms immediately because serious pulmonary toxicity is a recognized risk.
  • Pregnancy: Trastuzumab can cause fetal harm. Patients who are pregnant or may become pregnant should discuss appropriate precautions with their doctor.
  • Breastfeeding: Discuss breastfeeding with the treating physician before therapy.
  • Storage: Keep refrigerated at 2–8°C and do not freeze. Appropriate cold-chain handling is important.
  • Self-administration: Do not inject or prepare this medicine yourself.

10. FAQs

Q1. What is Herti 440mg Injection?
Herti 440mg is a trastuzumab-containing monoclonal antibody injection used for certain HER2-positive cancers.

Q2. What is the active ingredient in Herti 440mg?
The active ingredient is trastuzumab 440mg per vial.

Q3. What cancers can Herti 440mg treat?
It is used in appropriate patients with HER2-positive breast cancer and certain HER2-positive gastric or gastroesophageal junction cancers.

Q4. Is Herti 440mg a chemotherapy medicine?
It is a targeted monoclonal antibody, rather than a conventional cytotoxic chemotherapy drug.

Q5. How is Herti 440mg administered?
It is administered by intravenous infusion by qualified healthcare professionals.

Q6. Does Herti 440mg require refrigeration?
Yes. The product should generally be stored at 2–8°C and should not be frozen.

Q7. Can Herti 440mg be used for every breast cancer patient?
No. It is intended for cancers that meet the appropriate HER2-positive criteria and should be prescribed based on the patient's diagnosis and treatment plan.

Q8. Can Herti 440mg cause heart problems?
Yes. Trastuzumab carries an important risk of cardiomyopathy and decreased cardiac function, so cardiac monitoring is important.

Q9. Can Herti 440mg be used during pregnancy?
Trastuzumab may cause fetal harm and should not be used during pregnancy unless specifically determined appropriate by the treating specialist.

Q10. Can Herti 440mg be self-administered?
No. It requires professional preparation and intravenous administration.

11. Substitute for Herti 440mg Injection

Because Herti 440mg contains trastuzumab, possible alternatives may include other trastuzumab products. However, a substitute should not be selected solely on the basis of the same strength.

The appropriate alternative depends on the patient's diagnosis, formulation, regulatory availability, treatment protocol and physician's decision. One currently listed same-composition alternative is Kintsugi 440mg Injection, but substitution should be approved by the treating oncologist or pharmacist.

12. SEO Keywords

  • Herti 440mg Injection exporter from India
  • Herti 440mg Injection supplier India
  • Herti 440mg Trastuzumab Injection exporter
  • Herti 440mg Injection pharmaceutical exporter
  • Herti 440mg Injection wholesale supplier
  • Trastuzumab 440mg Injection exporter India
  • Trastuzumab 440mg pharmaceutical supplier
  • Herti 440mg Injection manufacturer supplier
  • Herti 440mg Injection export from Nagpur
  • Herti 440mg Injection supplier from Nagpur India
  • HER2 positive cancer medicine exporter
  • Trastuzumab Injection supplier India
  • Herti 440mg Injection for breast cancer
  • Herti 440mg Injection for gastric cancer
  • Herti 440mg Injection global supplier
  • Herti 440mg Injection exporter to USA
  • Herti 440mg Injection exporter to UK
  • Herti 440mg Injection exporter to Australia
  • Herti 440mg Injection exporter to Singapore
  • Herti 440mg Injection exporter to Canada
  • Herti 440mg Injection exporter to South Korea
  • Herti 440mg Injection exporter to UAE
  • Genuine Herti 440mg Trastuzumab supplier
  • Trastuzumab 440mg oncology medicine exporter
  • Herti 440mg cold chain pharmaceutical supplier
Aug 22nd, 2026 1:00 PM

Keywords